Axis CRISIL IBX 50:50 Gilt Plus SDL June 2028 Index Fund
Regular Plan · Growth Option · Axis Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.26% | +3.19% | 227 of 283 |
| 1M | +0.19% | +2.85% | 242 of 283 |
| 3M | +0.64% | -2.37% | 70 of 283 |
| 6M | +2.54% | +1.56% | 87 of 278 |
| YTD | +3.59% | -0.86% | 75 of 283 |
| 1Y | +4.58% | -0.15% | 58 of 263 |
| 2Y | +6.40% | +2.58% | 41 of 193 |
| 3Y | +7.26% | +9.71% | 99 of 142 |
| INCEPTION | +7.04% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +1.79% | +3.89% | +0.03% | 100% | 41% |
| 6M | +3.56% | +5.80% | +1.39% | 100% | 41% |
| 1Y | +7.55% | +10.52% | +3.93% | 100% | 43% |
| 2Y | +7.82% | +8.72% | +6.28% | 100% | 43% |
| 3Y | +7.37% | +8.02% | +6.78% | 100% | 43% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity0.00%
- Debt96.25%
- Cash3.74%
- Other0.01%
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others100.00%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| 706GS28M23 | Debt | 35.62% | -0.19% |
| 805TN2028 | Debt | 31.66% | -0.12% |
| 8.09% West Bengal State Development Loans (27/03/2028) | Debt | 13.84% | -0.05% |
| 718GUJSDL28 | Debt | 8.93% | -0.03% |
| Net Receivables / (Payables) | Net Current Assets | 2.85% | — |
| 8.44% Rajasthan State Development Loans (07/03/2028) | Debt | 1.51% | -0.01% |
| 8.16% Rajasthan State Development Loans (09/05/2028) | Debt | 1.51% | +0.00% |
| 8% Kerala State Development Loans (11/04/2028) | Debt | 1.50% | -0.01% |
| 815TN2028 | Debt | 1.09% | +0.00% |
| Clearing Corporation of India Ltd | Net Current Assets | 0.89% | — |
| SDL KL 6.73% 2028 | Debt | 0.59% | +0.00% |
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.07 | 12.38 | Low Volatility |
| 3Y | 1.06 | 10.25 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.94 | -0.51 | Below Average |
| 3Y | 0.95 | 0.26 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 6.47 | 12.56 | Below Average |
| 3Y | 13.38 | 8.16 | Above Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Tracking Difference
Versus CRISIL IBX 50:50 Gilt Plus SDL Index June 2028, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+19.89% | — | — | +21.71% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+19.31% | — | — | +16.06% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+17.24% | — | — | +17.73% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+17.19% | — | — | +11.55% |
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+15.21% | +27.99% | +16.74% | +17.49% |
|
Bandhan BSE Healthcare Index Fund
Regular Plan · Growth
|
+13.22% | — | — | +7.26% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+13.06% | — | — | +4.19% |
More From Axis Asset Management Co. Ltd.
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Axis Silver ETF | +26.40% | +35.94% | — | +33.11% |
|
Axis Silver Fund of Fund
Direct Plan · Growth Option
|
+25.78% | +35.80% | — | +33.62% |
|
Axis Gold Fund
Direct Plan · Growth option
|
+16.88% | +30.78% | +23.12% | +10.32% |
| Axis Gold ETF | +16.64% | +30.81% | +23.30% | +11.67% |
|
Axis NASDAQ 100 US Specific Equity Passive FOF
Direct Plan · IDCW Option
|
+15.62% | +27.97% | — | +30.61% |
| Axis NIFTY Healthcare ETF | +13.26% | +21.08% | +14.40% | +13.81% |
|
Axis Global Equity Alpha Fund of Fund
Direct Plan · Growth Option
|
+13.25% | +22.73% | +13.92% | +16.86% |
|
Axis India Manufacturing Fund
Direct Plan · IDCW Option
|
+13.04% | — | — | +18.81% |
|
Axis Global Innovation Fund of Fund
Direct Plan · IDCW Option
|
+9.94% | +22.97% | +11.52% | +12.36% |
|
Axis Innovation Fund
Direct Plan · Growth Option
|
+9.66% | +17.73% | +10.46% | +14.81% |
About This Scheme
Investment Objective
The investment objective of the scheme is to provide investment returns corresponding to the total returns of the securities as represented by the CRISIL IBX 50:50 Gilt Plus SDL Index – June 2028 before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved
Stated Asset Allocation
Debt Instruments comprising CRISIL IBX 50:50 Gilt Plus SDL Index – June 2028 - 95% to 100%; Debt & Money Market Instruments - 0% to 5%
Exit Load
Nil
Fund Managers
Mr. Hardik Shah
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch